Influx Healthtech Ltd
₹1,09,200 / 1200 Shares
Minimum Investment
18 Jun 2025
20 Jun 2025
1200
₹1,09,200
Influx Healthtech Limited is a Mumbai-based healthcare company that is in the contract manufacturing space. Established in 2020, it operates as a contract development and manufacturing organisation (CDMO), providing services across various industries. The company’s product offerings include dietary and nutritional supplements, cosmetics, Ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. These are available in multiple forms, including tablets, capsules, powders, liquids, softgels, and creams. Influx Healthtech operates manufacturing facilities in Thane, Maharashtra. The facilities are certified to international quality standards, including Good Manufacturing Practice (GMP), Hazard Analysis and Critical Control Points (HACCP), and Halal.
2020
Mr Munir Abdul Ganee Chandniwala
Influx Healthtech Ltd
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Regular | ₹91 - ₹96 | ₹2 Lakh |
| High Networth Individual | ₹91 - ₹96 | ₹2 - 5 Lakh |
Yes, nominal charges apply for account maintenance and fund management, but they are among the lowest in the industry.
Absolutely, SIPs help accumulate funds steadily over time so major purchases like home or car become financially stress-free.
KSquare offers tailored advice, easy KYC, global access, compliance support, and personal service for NRI investors.
Partial withdrawals of up to 25% are allowed after 3 years for specific purposes like medical emergencies, education, or house purchase.
While credit score matters, lenders also consider the value and type of mutual funds pledged. KSquare helps assess your eligibility beforehand.
Like regular funds, NFOs may involve expense ratios and entry/exit loads. KSquare discloses all costs transparently.
You can withdraw 60% of the corpus at retirement tax-free and use 40% to buy an annuity for regular income.
Yes, KSquare offers fund highlights, investment strategy, and expert opinions to help you evaluate each NFO thoroughly.